The post frames those two approvals as the turning point
FOR WEGOVY IS APPROVED SOURCE: DailyMed
Whether retatrutide eventually reaches approval or you start a compounded semaglutide or tirzepatide protocol now, the same genetic baseline gives the prescribing clinician a measurable starting point rather than a population-average schedule
The right one depends on your other conditions, insurance coverage, tolerance, and goals which is exactly why this belongs in a rheumatologists hands, not a weight-loss clinics
These medications work by mimicking the effects of GLP-1 in the body, leading to enhanced insulin secretion, reduced glucagon production, and increased satiety, thereby improving blood sugar control and promoting weight loss
It hasnt been thoroughly tested for safety or efficacy, which means this weight loss drug could put your health at risk